title: The efficacy of "Abound™," a nutritional supplement containing L-glutamine, L-arginine, citric acid, and calcium HMB, for skin disorders that developed as adverse drug reactions to anti-EGFR antibody preparation administration: pilot study.
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan.
authors.forename: Nobuhisa
authors.initials: N
authors.lastname: Matsuhashi
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan.
authors.forename: Takao
authors.initials: T
authors.lastname: Takahashi
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan.
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Tanahashi
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Matsui
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan.
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Sasaki
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan.
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Tanaka
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan.
authors.forename: Naoki
authors.initials: N
authors.lastname: Okumura
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan.
authors.forename: Kazuya
authors.initials: K
authors.lastname: Yamaguchi
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan.
authors.forename: Shinji
authors.initials: S
authors.lastname: Osada
authors.affiliation: Department of Surgical Oncology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City, 501-1194, Japan. kyoshida@gifu-u.ac.jp.
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Yoshida
mesh_terms: D000368:Aged; D000906:Antibodies / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001120:Arginine / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use*; D019343:Citric Acid / Q000627:therapeutic use*; D019587:Dietary Supplements; D064420:Drug-Related Side Effects and Adverse Reactions; D066246:ErbB Receptors / Q000276:immunology; D005260:Female; D005973:Glutamine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012871:Skin Diseases / Q000139:chemically induced / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D005973:Glutamine; D019343:Citric Acid; D001120:Arginine; D066246:ErbB Receptors; D002118:Calcium